Medicare Enrolled

Candace Mahan

Nurse Practitioner - Family · Center, TX
630 HURST STREET, Center, TX 75935
9366571944
Registered in NPPES since 2017
NPI: 1831635614 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Mahan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Mahan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Mahan

Candace Mahan is a nurse practitioner - family in Center, TX, with 9 years of NPI registration.

Between the years covered by Open Payments, Mahan received a total of $5,027 from 30 pharmaceutical and/or device companies across 306 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Mahan is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration $5,027 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,027
Total received (2021-2024)
Avg $1,257/year across 4 years
Top 4% in TX for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
306
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,138
2023
$1,518
2022
$972
2021
$1,400

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$283
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
Astellas Pharma US Inc
$136
ABBVIE INC.
$131
Novo Nordisk Inc
$88
Lilly USA, LLC
$85
PFIZER INC.
$42
GlaxoSmithKline, LLC.
$37
Amgen Inc.
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Otsuka America Pharmaceutical, Inc.
$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Teva Pharmaceuticals USA, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Enterra Medical, Inc.
$17
Exact Sciences Corporation
$13
Top 3 companies account for 49.5% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$846
Boehringer Ingelheim Pharmaceuticals, Inc.
$638
Lilly USA, LLC
$516
Novo Nordisk Inc
$513
PFIZER INC.
$503
ABBVIE INC.
$393
AbbVie Inc.
$273
Bayer Healthcare Pharmaceuticals Inc.
$225
Amgen Inc.
$210
Astellas Pharma US Inc
$136
Otsuka America Pharmaceutical, Inc.
$126
GlaxoSmithKline, LLC.
$108
ITI, Inc.
$82
IDORSIA PHARMACEUTICALS US INC
$68
Bayer HealthCare Pharmaceuticals Inc.
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Dexcom, Inc.
$25
Antares Pharma, Inc.
$24
Allergan, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$21
Axsome Therapeutics, Inc.
$17
Enterra Medical, Inc.
$17
Merck Sharp & Dohme Corporation
$16
Mylan Specialty L.P.
$15
Alkermes, Inc.
$15
Almatica Pharma LLC
$13
Exact Sciences Corporation
$13
Vifor Pharma, Inc.
$13
Top 3 companies account for 39.8% of all-time payments
Associated products mentioned in payments ›
ANORO ELLIPTA · AREXVY · Aimovig · Austedo XR · Auvelity · BREZTRI · CAPLYTA · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FASENRA · GRALISE · JANUVIA · JARDIANCE · Kerendia · LYBALVI · LifeVest · MOUNJARO · NOCDURNA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 13 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SPIRIVA RESPIMAT · SYNJARDY · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Veltassa · Veozah · Wegovy · XIFAXAN · YUPELRI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Center?
Compare family nurse practitioners in the Center area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
42
County median income
$50,436
Nearest hospital to ZIP centroid (approximate)
CHI ST LUKES HEALTH MEMORIAL SAN AUGUSTINE
15.7 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Mahan is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Mahan receive payments from pharmaceutical companies?
Yes. Mahan received a total of $5,027 from 30 companies across 306 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Mahan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Center
Browse family nurse practitioners in Center ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in TX
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in TX
Which TX family nurse practitioners receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →